 | ||
 |
 |
 |
 |
 |
 |
|
Business Strategy
Kane Biotech is a discovery and develoment company focused on novel products that prevent and disperse bacterial biofilms. The Company was formed to translate these discoveries into innovative healthcare solutions, with an initial focus on medical device coatings to prevent hospital acquired infections such as urinary tract and bloodstream infections caused by catheterization. Kane's commercial strategy is to create value for shareholders through the establishment of global partnerships and licensing agreements with leading companies to commercialize our innovations.
Discovery
- Internal discovery of novel technologies that inhibit and disperse biofilms and control microbial infections
- In-licensing of exclusive, novel biofilm technologies:
- University of North Texas Health Science Centre, Fort Worth, USA
- University of Medicine and Dentistry of New Jersey, USA
- University of Toronto, Canada
Development
- Develop and test prototypes
- Conduct pre-clinical performance tests
- Examine durability, stability and biocompatibility
- Joint development agreements or partner assisted clinical trials
Commercialization
- Partnerships or licensing agreements are developed with leading companies to manufacture and commercialize products.
